Separation of Drug Scheduling Powers

134 Yale Law Journal Forum 976 (2025)

46 Pages Posted: 18 Mar 2025 Last revised: 29 Mar 2025

See all articles by Mason Marks

Mason Marks

Florida State University - College of Law; Harvard University - Harvard Law School; Yale University - Information Society Project

Date Written: March 01, 2025

Abstract

Drug scheduling places substances believed to be harmful and addictive under strict federal control. In 1970, Congress enacted the Controlled Substances Act (CSA), which split drug scheduling authority between executive departments to leverage their specialized expertise. Today, the CSA grants the Department of Health and Human Services (HHS) authority over scientific aspects of drug scheduling and the Drug Enforcement Administration (DEA) jurisdiction over nonscientific, law-enforcement-related matters. However, since 1970, the separation of scheduling powers has collapsed, and law enforcement officials have assumed powers reserved for public health experts. Bureaucratic drift, where policies diverge from what lawmakers attempted to achieve, has produced redundant responsibilities and unscientific scheduling outcomes that contradict the CSA text, purpose, and legislative history. 

Statutory reforms could produce a more rational and reliable system. However, many shortcomings of drug scheduling stem from misinterpreting how the CSA splits agency authority. To produce more effective and economical scheduling actions, HHS should embrace its substantial yet frequently overlooked scheduling powers, including a categorical drug control veto that can override DEA regulatory proposals, as well as a more nuanced scheduling veto, which can guide and even constrain DEA scheduling options. DEA should conserve limited law enforcement resources and maintain the separation of scheduling powers by focusing on nonscientific aspects of drug scheduling. Courts, Congress, and the White House can also play a role.

Keywords: drug scheduling, drug control, controlled substances act, DEA, FDA, HHS, NIDA, public health, administrative law, regulation, agency authority, agency power, rulemaking, , MDMA, rescheduling, marijuana, Biden, Trump, OLC, drug

Suggested Citation

Marks, Mason, Separation of Drug Scheduling Powers (March 01, 2025). 134 Yale Law Journal Forum 976 (2025), Available at SSRN: https://ssrn.com/abstract=5174715 or http://dx.doi.org/10.2139/ssrn.5174715

Mason Marks (Contact Author)

Florida State University - College of Law ( email )

425 W. Jefferson Street
Tallahassee, FL 32306
United States

Harvard University - Harvard Law School ( email )

1563 Massachusetts Avenue
Cambridge, MA 02138
United States

Yale University - Information Society Project ( email )

P.O. Box 208215
New Haven, CT 06520-8215
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
137
Abstract Views
708
Rank
455,503
PlumX Metrics